Remove Collaboration Remove De-Escalation Remove Diagnostics
article thumbnail

Structuring the Right Deals for Growth in Life Sciences

Healthcare Law Insights blog

Whether a company is developing AI-driven diagnostics, biotech therapies, connected medical devices, or digital health solutions, success hinges on how well deals are structured. The FDA is closely monitoring machine learning-enabled devices, real-world data in clinical algorithms, and AI-powered diagnostics.